Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesotherapy versus dry needling for lateral epicondylitis
2024-519158-34-00Phase 2Authorised
- Sponsor
- ULS Santa Maria
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lidocaine, piroxicam and ketorolac in Lateral Epicondylitis (LET) (3 arms), sponsored by ULS Santa Maria. Primary endpoint: Primary: change from baseline in pain intensity on VAS. Planned start Jan 2025; status: authorised.
02
Drugs
lidocainepiroxicamketorolac
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on 2024-519158-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519158-34-00.